Aripiprazole: novelty, adherence and understatement.
Christopher
C
Fear
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000068180:Aripiprazole; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D010349:Patient Compliance / Q000523:psychology*; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D015363:Quinolones / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D013810:Therapeutic Equivalency
D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole; D006220:Haloperidol